A muscarinic M1 receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Trihexyphenidyl (hydrochloride)

Item No. 27643

Technical Information
Formal Name
α-cyclohexyl-α-phenyl-1-piperidinepropanol, monohydrochloride
CAS Number
52-49-3
Synonyms
  • Benzhexol hydrochloride
Molecular Formula
C20H31NO • HCl
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 2 mg/mlDMSO: 2 mg/mlEthanol: 3 mg/mlEthanol:PBS (pH 7.2) (1:4): 0.2 mg/ml
SMILES
OC(CCN1CCCCC1)(C2=CC=CC=C2)C3CCCCC3.Cl
InChi Code
InChI=1S/C20H31NO.ClH/c22-20(18-10-4-1-5-11-18,19-12-6-2-7-13-19)14-17-21-15-8-3-9-16-21;/h1,4-5,10-11,19,22H,2-3,6-9,12-17H2;1H
InChi Key
QDWJJTJNXAKQKD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Product Description

    Trihexyphenidyl is an antagonist of M1 muscarinic acetylcholine receptors.1 It binds to rat M1 receptors in cerebral cortex selectively over rat M2 receptors in heart tissue (IC50s = 3.7 and 31 nM, respectively). Trihexyphenidyl inhibits contractions induced by acetylcholine (Item No. 23829) in guinea pig ileum (IC50 = 22 nM).2 It also inhibits oxotremorine-induced tremors and physostigmine-induced mortality in mice (ED50s = 2 and 3.6 mg/kg, respectively). Trihexyphenidyl (20 mg/kg) improves abnormal movement in a mouse model of L-3,4-dihydroxyphenylalanine (L-DOPA) responsive dystonia (DRD) that expresses mutant tyrosine hydroxylase (TH).3 Formulations containing trihexyphenidyl have been used in the symptomatic treatment of Parkinson's disease.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Giachetti, A., Giraldo, E., Ladinsky, H., et alBinding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br. J. Pharmacol. 89(1), 83-90 (1986).

    2. Fjalland, B., Christensen, A.V., and Hyttel, J. Peripheral and central muscarinic receptor affinity of psychotropic drugs. Naunyn. Schmiedebergs. Arch. Pharmacol. 301(1), 5-9 (1977).

    3. Rose, S.J., Yu, X.Y., Heinzer, A.K., et alA new knock-in mouse model of ʟ-DOPA-responsive dystonia. Brain 138(Pt 10), 2987-3002 (2015).